AI assistant
Sending…
PROKIDNEY CORP. — Director's Dealing 2026
Mar 3, 2026
32485_dirs_2026-03-03_db10e513-d8b9-4f2f-8273-f75b1d2a74f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2026-03-01
Reporting Person: Coulston James (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-03-01 | Employee stock option (right to buy) | $2.24 | A | 600000 | Acquired | 2036-03-01 | Class A Common Stock (600000) | Direct |
Footnotes
F1: The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2026.
More from PROKIDNEY CORP.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 18
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 2
Regulatory Filings
2026
Jan 12